205 related articles for article (PubMed ID: 19699309)
1. The fascination with probiotics for Clostridium difficile infection: lack of evidence for prophylactic or therapeutic efficacy.
Miller M
Anaerobe; 2009 Dec; 15(6):281-4. PubMed ID: 19699309
[TBL] [Abstract][Full Text] [Related]
2. Evidence-based review of probiotics for antibiotic-associated diarrhea and Clostridium difficile infections.
McFarland LV
Anaerobe; 2009 Dec; 15(6):274-80. PubMed ID: 19825425
[TBL] [Abstract][Full Text] [Related]
3. Probiotics for Clostridium difficile-associated diarrhea: focus on Lactobacillus rhamnosus GG and Saccharomyces boulardii.
Segarra-Newnham M
Ann Pharmacother; 2007 Jul; 41(7):1212-21. PubMed ID: 17595306
[TBL] [Abstract][Full Text] [Related]
4. Probiotics for children with diarrhea: an update.
Guandalini S
J Clin Gastroenterol; 2008 Jul; 42 Suppl 2():S53-7. PubMed ID: 18520336
[TBL] [Abstract][Full Text] [Related]
5. Probiotics for prevention and treatment of diarrhea.
Guandalini S
J Clin Gastroenterol; 2011 Nov; 45 Suppl():S149-53. PubMed ID: 21992955
[TBL] [Abstract][Full Text] [Related]
6. Meta-analysis of probiotics for the prevention of antibiotic associated diarrhea and the treatment of Clostridium difficile disease.
McFarland LV
Am J Gastroenterol; 2006 Apr; 101(4):812-22. PubMed ID: 16635227
[TBL] [Abstract][Full Text] [Related]
7. Is primary prevention of Clostridium difficile infection possible with specific probiotics?
Johnson S; Maziade PJ; McFarland LV; Trick W; Donskey C; Currie B; Low DE; Goldstein EJ
Int J Infect Dis; 2012 Nov; 16(11):e786-92. PubMed ID: 22863358
[TBL] [Abstract][Full Text] [Related]
8. Probiotics in clostridium difficile Infection.
Na X; Kelly C
J Clin Gastroenterol; 2011 Nov; 45 Suppl(Suppl):S154-8. PubMed ID: 21992956
[TBL] [Abstract][Full Text] [Related]
9. Probiotics as prevention and treatment for diarrhea.
Guarino A; Lo Vecchio A; Canani RB
Curr Opin Gastroenterol; 2009 Jan; 25(1):18-23. PubMed ID: 19114770
[TBL] [Abstract][Full Text] [Related]
10. Prevention of Clostridium difficile infection with Saccharomyces boulardii: a systematic review.
Tung JM; Dolovich LR; Lee CH
Can J Gastroenterol; 2009 Dec; 23(12):817-21. PubMed ID: 20011734
[TBL] [Abstract][Full Text] [Related]
11. Review article: yeast as probiotics -- Saccharomyces boulardii.
Czerucka D; Piche T; Rampal P
Aliment Pharmacol Ther; 2007 Sep; 26(6):767-78. PubMed ID: 17767461
[TBL] [Abstract][Full Text] [Related]
12. Probiotics in the prevention and treatment of gastrointestinal infections.
Huebner ES; Surawicz CM
Gastroenterol Clin North Am; 2006 Jun; 35(2):355-65. PubMed ID: 16880070
[TBL] [Abstract][Full Text] [Related]
13. Recurrent Clostridium difficile infection: causality and therapeutic approaches.
Johnson S
Int J Antimicrob Agents; 2009 Mar; 33 Suppl 1():S33-6. PubMed ID: 19303567
[TBL] [Abstract][Full Text] [Related]
14. Fecal bacteriotherapy for recurrent Clostridium difficile infection.
Bakken JS
Anaerobe; 2009 Dec; 15(6):285-9. PubMed ID: 19778623
[TBL] [Abstract][Full Text] [Related]
15. European Society of Clinical Microbiology and Infectious Diseases (ESCMID): treatment guidance document for Clostridium difficile infection (CDI).
Bauer MP; Kuijper EJ; van Dissel JT;
Clin Microbiol Infect; 2009 Dec; 15(12):1067-79. PubMed ID: 19929973
[TBL] [Abstract][Full Text] [Related]
16. Prophylactic Saccharomyces boulardii in the prevention of antibiotic-associated diarrhea: a prospective study.
Can M; Beşirbellioglu BA; Avci IY; Beker CM; Pahsa A
Med Sci Monit; 2006 Apr; 12(4):PI19-22. PubMed ID: 16572062
[TBL] [Abstract][Full Text] [Related]
17. A clinical risk index for Clostridium difficile infection in hospitalised patients receiving broad-spectrum antibiotics.
Garey KW; Dao-Tran TK; Jiang ZD; Price MP; Gentry LO; Dupont HL
J Hosp Infect; 2008 Oct; 70(2):142-7. PubMed ID: 18723249
[TBL] [Abstract][Full Text] [Related]
18. Fecal bacteriotherapy for relapsing Clostridium difficile infection in a child: a proposed treatment protocol.
Russell G; Kaplan J; Ferraro M; Michelow IC
Pediatrics; 2010 Jul; 126(1):e239-42. PubMed ID: 20547640
[TBL] [Abstract][Full Text] [Related]
19. Lactobacillus and bifidobacteria combinations: a strategy to reduce hospital-acquired Clostridium difficile diarrhea incidence and mortality.
Graul T; Cain AM; Karpa KD
Med Hypotheses; 2009 Aug; 73(2):194-8. PubMed ID: 19359104
[TBL] [Abstract][Full Text] [Related]
20. Role of probiotics in antibiotic-associated diarrhea, Clostridium difficile-associated diarrhea, and recurrent Clostridium difficile-associated diarrhea.
Surawicz CM
J Clin Gastroenterol; 2008 Jul; 42 Suppl 2():S64-70. PubMed ID: 18545161
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
